- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2015
- Public Summary Document (PSD) March 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2015 PBAC Meeting - Word
Obinutuzumab – March 2015
Obinutuzumab; 1 g/40 mL injection, 40 mL vial; Gazyva®
Last updated
3 July 2015